ReviewCureus2026
Effectiveness of Opioids for Low Back Pain: A Systematic Review of Randomised Controlled Trials.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic low back pain (LBP) is a major cause of disability around the world, and pharmaceutical treatments like opioids are often used to treat it. However, the efficacy and safety of opioids in LBP continue to be controversial due to inconsistent results and associated side effects. This systematic review assesses the effectiveness and safety of opioid medication in the treatment of LBP. A systematic search was performed utilising various electronic databases, including PubMed, Scopus, Google Scholar, MEDLINE, the Cochrane Library, and Web of Science, following a structured methodology in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) principles. Randomised controlled trials that were published in English within the past two decades and evaluated the use of opioids in adults with LBP were included. The Cochrane Risk of Bias tool and the Critical Appraisal Skills Programme (CASP) checklist were used to screen for bias, and a narrative synthesis was done because the studies were not all the same. There were six randomised, double-blind, placebo-controlled trials involving between 83 and 905 people. Opioid formulations, including buprenorphine, hydrocodone, oxycodone/naloxone, and oxymorphone, exhibited overall efficacy in diminishing pain intensity relative to placebo, especially in opioid-naïve individuals. But the magnitude and consistency of the advantage varied across studies, and some treatments showed only a small statistical difference. There were only a few reports of functional improvement, and they were not always constant. Nausea, constipation, and drowsiness were common side effects, although long-term safety outcomes were not fully evaluated. In general, opioids may help with short-term pain relief in people with LBP, but they aren't very useful in the long term because they aren't very effective and very safe and there isn't much evidence for their long-term use. It is advisable to select patients and use them with caution. More high-quality research is needed to understand their role in long-term management better.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.